A phase II study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma
Phase 2
Completed
- Conditions
- gastric cancer
- Registration Number
- JPRN-UMIN000003201
- Lead Sponsor
- Study group of multi-modality therapy for gastric cancer
- Brief Summary
This trial was terminated, because sufficient number of patients enrolled.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1) Tumor localization is not detected by neither CT, endoscopy nor upper GI series 2) Serious comorbidities 3) Severe GI obstruction or gastrointestinal bleeding 4) Current inflammation or acute inflammatory disease 5) Allergy to cremophor EL 6) Brain metastasis with symptom 7) Female with present pregnancy or breast-feeding, or contemplating pregnancy. 8) Registered to other clinical trial 9) Patients judged inappropriate for the study by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of gastrointestinal obstruction and/or localized pain
- Secondary Outcome Measures
Name Time Method Improved duration of gastrointestinal obstruction , survival time, adverse event